                         SEQUENCE LISTING

<110>  EKR Therapeutics, Inc.
 
<120>  Room Temperature Stable, Lyophilized Natriuretic Peptide 
       Formulations

<130>  19015-200

<140>  Not yet assigned
<141>  2008-12-19

<150>  US 61/014,986
<151>  2007-12-19

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  28
<212>  PRT
<213>  Homo sapiens

<400>  1

Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly 
1               5                   10                  15      


Ala Gln Ser Gly Leu Gly Cys Asn Ser Phe Arg Tyr 
            20                  25              


<210>  2
<211>  32
<212>  PRT
<213>  Homo sapiens

<400>  2

Ser Pro Lys Met Val Gln Gly Ser Gly Cys Phe Gly Arg Lys Met Asp 
1               5                   10                  15      


Arg Ile Ser Ser Ser Ser Gly Leu Gly Cys Lys Val Leu Arg Arg His 
            20                  25                  30          


<210>  3
<211>  32
<212>  PRT
<213>  Homo sapiens

<400>  3

Thr Ala Pro Arg Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met 
1               5                   10                  15      


Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly Cys Asn Ser Phe Arg Tyr 
            20                  25                  30          


